Robert V Swift1, Rommie E Amaro. 1. Department of Pharmaceutical Sciences, University of California, Irvine, Irvine, CA 92697, USA.
Abstract
BACKGROUND: Members of the nucleotidyltransferase superfamily known as DNA and RNA ligases carry out the enzymatic process of polynucleotide ligation. These guardians of genomic integrity share a three-step ligation mechanism, as well as common core structural elements. Both DNA and RNA ligases have experienced a surge of recent interest as chemotherapeutic targets for the treatment of a range of diseases, including bacterial infection, cancer, and the diseases caused by the protozoan parasites known as trypanosomes. OBJECTIVE: In this review, we will focus on efforts targeting pathogenic microorganisms; specifically, bacterial NAD(+)-dependent DNA ligases, which are promising broad-spectrum antibiotic targets, and ATP-dependent RNA editing ligases from Trypanosoma brucei, the species responsible for the devastating neurodegenerative disease, African sleeping sickness. CONCLUSION: High quality crystal structures of both NAD(+)-dependent DNA ligase and the Trypanosoma brucei RNA editing ligase have facilitated the development of a number of promising leads. For both targets, further progress will require surmounting permeability issues and improving selectivity and affinity.
BACKGROUND: Members of the nucleotidyltransferase superfamily known as DNA and RNA ligases carry out the enzymatic process of polynucleotide ligation. These guardians of genomic integrity share a three-step ligation mechanism, as well as common core structural elements. Both DNA and RNA ligases have experienced a surge of recent interest as chemotherapeutic targets for the treatment of a range of diseases, including bacterial infection, cancer, and the diseases caused by the protozoan parasites known as trypanosomes. OBJECTIVE: In this review, we will focus on efforts targeting pathogenic microorganisms; specifically, bacterial NAD(+)-dependent DNA ligases, which are promising broad-spectrum antibiotic targets, and ATP-dependent RNA editing ligases from Trypanosoma brucei, the species responsible for the devastating neurodegenerative disease, African sleeping sickness. CONCLUSION: High quality crystal structures of both NAD(+)-dependent DNA ligase and the Trypanosoma brucei RNA editing ligase have facilitated the development of a number of promising leads. For both targets, further progress will require surmounting permeability issues and improving selectivity and affinity.
Authors: R G Ridley; H Matile; C Jaquet; A Dorn; W Hofheinz; W Leupin; R Masciadri; F P Theil; W F Richter; M A Girometta; A Guenzi; H Urwyler; E Gocke; J M Potthast; M Csato; A Thomas; W Peters Journal: Antimicrob Agents Chemother Date: 1997-03 Impact factor: 5.191
Authors: Pravin A Nair; Jayakrishnan Nandakumar; Paul Smith; Mark Odell; Christopher D Lima; Stewart Shuman Journal: Nat Struct Mol Biol Date: 2007-07-08 Impact factor: 15.369
Authors: Steven Howard; Nader Amin; Andrew B Benowitz; Elisabetta Chiarparin; Haifeng Cui; Xiaodong Deng; Tom D Heightman; David J Holmes; Anna Hopkins; Jianzhong Huang; Qi Jin; Constantine Kreatsoulas; Agnes C L Martin; Frances Massey; Lynn McCloskey; Paul N Mortenson; Puja Pathuri; Dominic Tisi; Pamela A Williams Journal: ACS Med Chem Lett Date: 2013-10-18 Impact factor: 4.345